or Try an Advanced Search...

    Technical Analysis for TH - Theratechnologies Inc.

    Grade Last Price % Change Price Change
    F 1.770 0.00% 0.000
    TH closed unchanged on Tuesday, May 21, 2024, on 1.37 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical TH trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Wide Range Bar Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish 0.00%
    50 DMA Resistance Bearish -1.12%
    Gapped Up Strength -1.12%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.67%
    Older End-of-Day Signals for TH ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 3 hours ago
    Reversed from Up about 9 hours ago
    50 DMA Resistance about 9 hours ago
    20 DMA Resistance about 9 hours ago
    Fell Below 20 DMA about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TH Chart by TradingView
    Basic chart:

    Profile

    Theratechnologies Inc. Description

    Theratechnologies Inc. is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT), as assessed by waist circumference of approximately 100 centimeters for males and approximately 90 centimeters for females. Ibalizumab is a cluster difference 4 (CD4)-directed HIV entryinhibitor, which focuses on treating multidrug resistant HIV-1 infection (MDR HIV-1). ibalizumab binds to the second extracellular domain of the CD4 receptor. Ibalizumab has completed the Phase III trial. EGRIFTA is available in Canada and in the United States. The Company distributes EGRIFTA in the United States through RxC Acquisition Company.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Pharma Pharmaceutical Drug Medical Specialties IPO Organ Systems Immunology Hiv Infection Rift Antivirals

    Is TH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Theratechnologies Reports on its Annual Meeting of Shareholders
    May 2 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
    Apr 23 Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?
    Apr 15 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
    Apr 11 Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
    Apr 10 Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
    Apr 8 Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
    Apr 5 Theratechnologies Appoints Elina Tea to its Board of Directors
    Apr 3 Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update
    Mar 28 Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
    See more TH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.45
    52 Week Low 0.73
    Average Volume 18,360
    200-Day Moving Average 2.090
    50-Day Moving Average 1.825
    20-Day Moving Average 1.763
    10-Day Moving Average 1.730
    Average True Range 0.091
    RSI (14) 47.64
    ADX 17.73
    +DI 26.576
    -DI 20.225
    Chandelier Exit (Long, 3 ATRs) 1.646
    Chandelier Exit (Short, 3 ATRs) 1.884
    Upper Bollinger Bands 1.884
    Lower Bollinger Band 1.641
    Percent B (%b) 0.53
    BandWidth 13.787
    MACD Line -0.031
    MACD Signal Line -0.043
    MACD Histogram 0.0125
    Fundamentals Value
    Market Cap 136.31 Million
    Num Shares 77 Million
    EPS -0.09
    Price-to-Earnings (P/E) Ratio -19.89
    Price-to-Sales 2.87
    Price-to-Book 21.32
    PEG Ratio -199.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.085
    Resistance 3 (R3) 2.100 2.010 2.033
    Resistance 2 (R2) 2.010 1.930 2.003 2.015
    Resistance 1 (R1) 1.890 1.880 1.950 1.875 1.997
    Pivot Point 1.800 1.800 1.830 1.793 1.800
    Support 1 (S1) 1.680 1.720 1.740 1.665 1.543
    Support 2 (S2) 1.590 1.670 1.583 1.525
    Support 3 (S3) 1.470 1.590 1.508
    Support 4 (S4) 1.455